Literature DB >> 20847414

Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control.

Alla B Salmina1, Alyona I Inzhutova, Natalia A Malinovskaya, Marina M Petrova.   

Abstract

Current theories state that Alzheimer's disease (AD) is a vascular disorder that initiates its pathology through cerebral microvascular abnormalities. Endothelial dysfunction caused by the injury or death of endothelial cells contributes to progression of AD. Also, functional relationships between neurons, glial cells, and vascular cells within so-called neurovascular unit are dramatically compromised in AD. Several recent studies have highlighted that endothelial cells might be the target for the toxic action of heavily aggregated proteins, glia-derived cytokines, and stimuli inducing oxidative and metabolic stress in AD brains. Here, we describe the properties of the brain endothelium that contribute to its specific functions in the central nervous system, and how endothelial-neuronal-glial cell interactions are compromised in the pathogenesis of AD. We also discuss the ways in which functioning of endothelial cells can be modulated in cerebral microvessels. Understanding of molecular mechanisms of endothelial injury and repair in AD would give us novel diagnostic biomarkers and pharmacological targets.

Entities:  

Mesh:

Year:  2010        PMID: 20847414     DOI: 10.3233/JAD-2010-091690

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease.

Authors:  M C Polidori; C Ruggiero; M F Croce; T Raichi; F Mangialasche; R Cecchetti; L Pelini; L Paolacci; S Ercolani; P Mecocci
Journal:  J Neural Transm (Vienna)       Date:  2015-01-14       Impact factor: 3.575

2.  Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.

Authors:  Jaqueline Hatsuko Tamashiro-Duran; Paula Squarzoni; Fábio Luís de Souza Duran; Pedro Kallas Curiati; Homero Pinto Vallada; Carlos Alberto Buchpiguel; Paulo Andrade Lotufo; Mauricio Wajngarten; Paulo Rossi Menezes; Márcia Scazufca; Tânia Corrêa de Toledo Ferraz Alves; Geraldo Filho Busatto
Journal:  Age (Dordr)       Date:  2012-04-29

3.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

Review 4.  Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.

Authors:  Alla B Salmina; Ekaterina V Kharitonova; Yana V Gorina; Elena A Teplyashina; Natalia A Malinovskaya; Elena D Khilazheva; Angelina I Mosyagina; Andrey V Morgun; Anton N Shuvaev; Vladimir V Salmin; Olga L Lopatina; Yulia K Komleva
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

5.  Acetylcholinesterase inhibitors promote angiogenesis in chick chorioallantoic membrane and inhibit apoptosis of endothelial cells.

Authors:  Seyed Mohsen Mortazavian; Heydar Parsaee; Seyed Hadi Mousavi; Zahra Tayarani-Najaran; Ahmad Ghorbani; Hamid Reza Sadeghnia
Journal:  Int J Alzheimers Dis       Date:  2013-09-16

Review 6.  Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.

Authors:  Paula Grammas
Journal:  J Neuroinflammation       Date:  2011-03-25       Impact factor: 8.322

7.  Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease.

Authors:  Philip P Foster; Kevin P Rosenblatt; Rodrigo O Kuljiš
Journal:  Front Neurol       Date:  2011-05-06       Impact factor: 4.003

8.  Adipocytokines and CD34 progenitor cells in Alzheimer's disease.

Authors:  Boris Bigalke; Brigitte Schreitmüller; Kateryna Sopova; Angela Paul; Elke Stransky; Meinrad Gawaz; Konstantinos Stellos; Christoph Laske
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

9.  Alzheimer's disease and vascular deficiency: lessons from imaging studies and down syndrome.

Authors:  Arlene Reed-Cossairt; Xiongwei Zhu; Hyoung-Gon Lee; Charles Reed; George Perry; Robert B Petersen
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-15

Review 10.  H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?

Authors:  Alla B Salmina; Yulia K Komleva; István A Szijártó; Yana V Gorina; Olga L Lopatina; Galina E Gertsog; Milos R Filipovic; Maik Gollasch
Journal:  Front Physiol       Date:  2015-12-11       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.